Aging
Navigate
Back to articleFigure 5(5 of 7)
100%
Figure 5
Figure 5.Safety evaluation of the drug after 12 weeks of prophylactic administration. (A) Comparison of cardiac and liver and kidney function in each group. (B) HE staining of the heart, liver, and kidney in each group (100×).